Global Health Limited — Others, 07-08-2025: Change in Auditors

Global Health Limited's board has approved the financial results for the quarter ended June 30, 2025, reporting a consolidated revenue of ₹1,030.84 Cr and consolidated profit after tax of ₹158.98 Cr. The company has fixed the record date for a final dividend of ₹0.50 per equity share for FY24-25, pending shareholder approval at the upcoming 21st Annual General Meeting. Key re-appointments include Dr. Naresh Trehan as CMD for five years and Mr. Vikram Singh Mehta and Mr. Hari Shanker Bhartia as Independent Directors for five years each. Additionally, the company announced the acquisition of a 3.5-acre land parcel in Guwahati for a super speciality hospital, replacing an earlier offer. The board also approved an employee share-based incentive plan.